AlloSource
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, AlloSource sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
AlloSource: 7 sponsored US clinical trials, 2 recruiting.
AlloSource sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Pre-Pectoral Breast Reconstruction Following Mastectomy, with 1 trials.
Upper-quartile sponsor footprint
AlloSource sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee
NCT06216756
AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction
NCT06512259
Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction
NCT06853964
Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries
NCT05744414
Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
NCT03873545
ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry
NCT04301258
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
NCT01413061
What is open in the AlloSource pipeline
2 recruiting of 7 indexed (29% open); 1 completed (14%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Pre-Pectoral Breast Reconstruction Following Mastectomy (1 trial), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
AlloSource: open-pipeline peers nationwide
Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
AlloSource sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Alabama Physical Therapy & Acupuncture · 29% recruiting · 14 trials
- Alnylam Pharmaceuticals · 29% recruiting · 49 trials
- Annovis Bio · 29% recruiting · 7 trials
- Ascendis Pharma Endocrinology Division A/S · 29% recruiting · 7 trials
Related
What to do with this AlloSource page
7 registered trials is a research-attention snapshot, not an endorsement of AlloSource or any single study.
- 2 of AlloSource's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pre-Pectoral Breast Reconstruction Following Mastectomy is the condition AlloSource studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pre-Pectoral Breast Reconstruction Following Mastectomy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
AlloSource pipeline card: 7 registered trials from official public datasets.Report a data error.